Clinical Trial Update: Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate Responders [NA]

View source ↗

Summary

A clinical trial evaluating the administration of short-chain fatty acids (SCFA) in inadequate responders with rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Short-chain fatty acids (SCFA) (short-chain fatty acids)

Snippet

Sponsor: NYU Langone Health | Conditions: Rheumatoid Arthritis | NA | Status: COMPLETED